740 results on '"Chang, Yun Sil"'
Search Results
2. Therapeutic efficacy of thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles on Escherichia coli-induced acute lung injury in mice
3. Predictive factors for perinatal bacterial transmission from colonized mothers to delivered very-low-birth-weight infants: a retrospective cohort study
4. Long-term impact of late pulmonary hypertension requiring medication in extremely preterm infants with severe bronchopulmonary dysplasia
5. The effect of minimizing central line days for very low birth weight infants through quality improvement
6. Loop-mediated isothermal amplification assay for screening congenital cytomegalovirus infection in newborns
7. Variations in medical practice of retinopathy of prematurity among 8 Asian countries from an international survey
8. Impact of time to full enteral feeding on long-term neurodevelopment without mediating by postnatal growth failure in very-low-birth-weight-infants
9. Stem cells for neonatal brain injury – Lessons from the bench
10. Association Between Retinopathy of Prematurity in Very-Low-Birth-Weight Infants and Neurodevelopmental Impairment
11. Microbiologic Epidemiology of Early-onset Sepsis in Neonates Born at ≥35 0/7 Weeks’ Gestation in Korea During 2009–2018
12. Uncovering potential causal genes for undiagnosed congenital anomalies using an in-house pipeline for trio-based whole-genome sequencing.
13. Development of necrotizing enterocolitis in full-term infants with duct dependent congenital heart disease
14. Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants
15. Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity
16. Stem cell restores thalamocortical plasticity to rescue cognitive deficit in neonatal intraventricular hemorrhage
17. Mesenchymal stem cell therapy for intractable neonatal disorders
18. Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders.
19. Mesenchymal Stem Cells Reduce the Extracellular Mitochondrial DNA-Mediated TLR9 Activation in Neonatal Hyperoxia-Induced Lung Injury
20. Contemporary fluid management, humidity, and patent ductus arteriosus management strategy for premature infants among 336 hospitals in Asia
21. Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network
22. Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants
23. Cesarean section was not associated with mortality or morbidities advantage in very low birth weight infants: a nationwide cohort study
24. Physical exercise enhances adult cortical plasticity in a neonatal rat model of hypoxic-ischemic injury: Evidence from BOLD-fMRI and electrophysiological recordings
25. Current Status and Associated Factors of Post-hemorrhagic Hydrocephalus in Infants of 22 to 28 Weeks Gestation With Severe Intraventricular Hemorrhage in Korea: A Nationwide Cohort Study
26. Quality Improvement Project to Reduce Admission Hypothermia of Preterm Infants Born at Less than 32 Weeks or 1,500 g.
27. Clinical Characteristics of Hypospadias and Its Association with Very Low Birth Weight Infants with Small for Gestational Age.
28. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles
29. Outcome and risk factors associated with perirenal subcapsular fluid collections in extremely preterm infants with acute kidney injury
30. Optimal Protocols and Management of Clinical and Genomic Data Collection to Assist in the Early Diagnosis and Treatment of Multiple Congenital Anomalies
31. Changes to Blood-Sampling Protocol to Reduce the Sampling Amount in Neonatal Intensive Care Units: A Quality Improvement Project
32. Optimal Protocols of Clinical and Genomic Data Collection for Prevention and Management of Congenital Anomalies
33. Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia
34. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia
35. Author Correction: Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation
36. Survival rate dependent variations in retinopathy of prematurity treatment rates in very low birth weight infants
37. Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation
38. Stem cells in the treatment of bronchopulmonary dysplasia
39. Contributors
40. Mesenchymal stem cells transplantation attenuates brain injury and enhances bacterial clearance in Escherichia coli meningitis in newborn rats
41. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury
42. Blood Sampling Protocol Changes to Reduce the Sampling Amount in Neonatal Intensive Care Unit: A Quality Improvement Project
43. SOCS3 Protein Mediates the Therapeutic Efficacy of Mesenchymal Stem Cells against Acute Lung Injury
44. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants
45. Neuroplasticity for spontaneous functional recovery after neonatal hypoxic ischemic brain injury in rats observed by functional MRI and diffusion tensor imaging
46. Mortality Rate-Dependent Variations in the Timing and Causes of Death in Extremely Preterm Infants Born at 23–24 Weeks’ Gestation*
47. Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants
48. Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants
49. Mortality rate-dependent variations in the survival without major morbidities rate of extremely preterm infants
50. WKYMVm hexapeptide, a strong formyl peptide receptor 2 agonist, attenuates hyperoxia-induced lung injuries in newborn mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.